THanks groins. Just looked up the other stock's chart to...

THanks groins. Just looked up the other stock's chart to determine what could happen to prr. The other stock had a dramatic rise from approx $1 to $2.50 around dual listing time, followed by a more dramatic fallto 50c, then ranged b/w 50c and $1, before further tumbles to trading low 20's to high 60's over the past five years. Obviously their discoveries were not as commercially acceptable as frst thought, although as with prima we must accept that all things take time. Also their listing was in 2002, when poss not even the yanks were fully cognisant of biotech's potential. But from looking at the chart for pbt pre listing, it seems that the listing price was already factored in at listing. As such maybe as has been said, the true value of prima will be in the product/phase III success/failure over the next 12 -18 months. We should not expect that prr will skyrocket on listing (though I would be happy to be wrong).